Orthmann, A; Hoffmann, A; Zeisig, R; EL-Heliebi, A; Ernst, C; Hayback, J; Jodicke, A; Kuhn, S; Linnebacher, M; Hoffmann, J; Fichtner, I.
Therapeutic response to bevacicumab, irinotecan, and temozolomide of PDX from human glioma cannot be correlated to common mutations as routinely identified by panel sequencing
CANCER RES. 2015; 75:
Doi: 10.1158/1538-7445.BRAIN15-B24
Web of Science
FullText
FullText_MUG